References
- Fox RI, Kang HI. Pathogenesis of SjOgren's syndrome. Rheum Dis Clin North Am 1992;18:517–38.
- Konttinen YT, Hukkanen M, Kemppinen P, Segerberg M, Sorsa T, Malmström M, Rose S, Itescu S, Polak JM. Peptide-containing nerves in labial salivary glands in Sjogren's syndrome. Arthritis Rheum 1992;35:815–20.
- Bergroth V, Konttinen YT, Segerberg-Konttinen M, O11ikainen V, Salaspuro M. Phenotypic in situ characterization of lympho-cytes in mild alcoholic liver diseases. Acta Pathol Microbiol Scand Sect 1986;A 94:337–41.
- Nagaraju K, Cox A, Casciola-Rosen L, Rosen A. Novel frag-ments of the Sjogren's syndrome autoantigens ce-fodrin and type 3 muscarinic acetylcholine receptor generated during cyto-toxic lymphocyte granule-induced cell death. Arthritis Rheum 2001;44: 2376 —86.
- Jonsson R, Haga HJ, Gordon TP. Current concepts on diagnosis, autoantibodies and therapy in Sjogren's syndrome. Scand J Rheumatol 2000;29:341 —8.
- Törnwall J, Konttinen YT, Tuominen RK, Törnwall M. Salivary gland acinar epithelial cells are deficient in their protein kinase C expression in Sjogren's syndrome. Lancet 1997;349:1814 —5.
- Nguyen KH, Brayer J, Cha S, Diggs S, Yasunari U, Hilal G, Peck AB, Humphreys-Beher MG. Evidence for antimuscarinic acetylcholine receptor antibody-mediated secretory dysfunction in NOD mice. Arthritis Rheum 2000;43:2297 —306.
- Valtysdottir ST, Wide L, Hällgren R. Low serum dehydroepian-drosterone sulfate in women with primary Sjogren's syndrome as an isolated sign of impaired HPA axis function. J Rheumatol 2001;28:1259–65.